IGF2BP2 binds to m6A‐modified mRNA, increasing its stability and translation and thus regulating key genes involved in the glutamine metabolic pathway, such as MYC, GPT2, and solute carrier family 1 member 5 (SLC1A5), promoting acute myeloid leukemia (AML) cell proliferation and leukemia stemness/self‐renewal.162. This evidence concerns the gene IGF2BP2 and acute myeloid leukemia.